Skip to main content
. Author manuscript; available in PMC: 2023 Jun 14.
Published in final edited form as: Eur Urol. 2021 May 10;80(2):142–146. doi: 10.1016/j.eururo.2021.04.035

Fig. 1 –

Fig. 1 –

Kaplan-Meier curves for (A,B) distant metastasis–free survival and (C,D) prostate cancer–specific survival following biochemical recurrence (BCR) in men with high-risk prostate cancer treated initially with external beam radiotherapy (EBRT) or external beam radiotherapy plus brachytherapy boost (EBRT + BT). (A) Distant metastasis–free survival following BCR after EBRT. (B) Distant metastasis–free survival following BCR after EBRT + BT. (C) Prostate cancer–specific survival following BCR after EBRT. (D) Prostate cancer–specific survival following BCR after EBRT + BT.